Multi-Scale Signaling Functions of Food-Derived Lipids in Health and Disease: Recent Advances and Implications for Precision Nutrition
Preprint
- 25 May 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Food-derived lipids are not only major sources of dietary energy but are increasingly recognized as active signaling molecules and dynamic regulators of immunometabolic homeostasis. This review proposes an integrated framework of multi-scale lipid signaling organized around four major regulatory axes: immune-inflammation, metabolic reprogramming, membrane structural dynamics, and organelle stress responses. Within this framework, we systematically summarize how major classes of functional food-derived lipids, including n-3 polyunsaturated fatty acids (PUFAs), short-chain fatty acids (SCFAs), phospholipids, phytosterols, and medium-chain triglycerides (MCTs), coordinately regulate health-related processes at the molecular, subcellular, and cellular levels. We further discuss their potential protective roles and translational evidence in cardiovascular disease, neurodegenerative disorders, intestinal inflammatory diseases, and cancer-related nutritional support. In addition, we examine how lipidomics, multi-omics integration, and artificial intelligence are driving the field from empirical use toward mechanism-guided precision nutrition. Finally, we highlight major challenges that currently limit clinical translation, including bioavailability, interindividual heterogeneity in responsiveness, variation in endpoint selection, and the need for more rigorous validation of causal mechanisms. Overall, this review provides a systematic perspective on the signaling functions of food-derived lipids and their emerging potential in precision nutrition and disease management.Keywords
All Related Versions
This publication has 70 references indexed in Scilit:
- Molecular Mechanisms of Lipid‐Modifying Enzymes in Cellular Adaptation and Systemic Glucose HomeostasisComprehensive Physiology, 2026
- Dietary Phytochemicals in Cardiovascular Disease Prevention and Management: A Comprehensive ReviewFood Science & Nutrition, 2025
- Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic PotentialJournal of Cardiovascular Translational Research, 2025
- Gut microbiota-derived short chain fatty acids act as mediators of the gut-liver-brain axisMetabolic Brain Disease, 2025
- A Potential Role for Gut Microbes in Mediating Effects of Omega-3 Fatty Acids in Inflammatory Bowel Diseases: A Comprehensive ReviewCurrent Microbiology, 2023
- Interface between Resolvins and Efferocytosis in Health and DiseaseCell Biochemistry and Biophysics, 2023
- Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density LipoproteinsCurrent Atherosclerosis Reports, 2023
- The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and ControversiesAdvances in Nutrition, 2023
- Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate ContinuesCurrent Atherosclerosis Reports, 2022
- Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathwayNaunyn-Schmiedeberg's Archives of Pharmacology, 2021